FDA (Drugs) recall action 97202
The FDA (Drugs) publishes a recall like this one as 4 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 4 pages.
Subpotent Drug
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Semaglutide 2.5 mg/mL injection, 4 mL, from Boothwyn Pharmacy is recalled nationwide as a subpotent drug. 648 vials are affected.
Semaglutide 2.5 mg/mL injection, 2 mL, from Boothwyn Pharmacy is recalled nationwide as a subpotent drug. 642 vials are affected.
Semaglutide 2.5 mg/mL injection, 0.8 mL, from Boothwyn Pharmacy is recalled nationwide as a subpotent drug. 186 vials are affected.
Fluorescein 2% Ophthalmic, 3 mL, from Boothwyn Pharmacy is recalled nationwide as a subpotent drug. 8 vials are affected.